Literature DB >> 32623534

Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits.

Mayara Rodrigues Brandão de Paiva1,2, Raquel Gregório Arribada1, Carolina Nunes da Silva1, Marcela Coelho Silva Ribeiro1, Rodrigo Jorge3, Silvia Ligório Fialho2, Armando Silva-Cunha4.   

Abstract

PURPOSE: To verify the safety of different doses of intravitreal metoprolol tartrate (MT) after intravitreal injection in rabbit eyes.
METHODS: Animals were randomly assigned into 2 groups: group I received 50 µg of MT and group II 100 µg of MT. A volume of 0.05 mL of the drug solution was administered through an intravitreal injection, while the control eyes received an equal volume of saline solution. Safety was assessed by clinical observation, electroretinography (ERG) and histological evaluation.
RESULTS: No evidence of clinical toxicity was observed. ERG waveforms from the MT treated eyes were similar to those recorded from the control eyes in dark-adapted state, amplitude and the implicit time are similar between the groups in light-adapted state, and their retinas had no signs of toxicity by histological evaluation 7 days after intravitreal injection.
CONCLUSIONS: The intravitreal use of metoprolol at 50 and 100 µg dosages does not cause short-term retinal toxicity in rabbits.

Entities:  

Keywords:  Electroretinography; Intravitreal injection; Metoprolol tartrate

Mesh:

Substances:

Year:  2020        PMID: 32623534     DOI: 10.1007/s10633-020-09781-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT.

Authors:  Andrew Tatham; Adrian Macfarlane
Journal:  J Ocul Pharmacol Ther       Date:  2006-04       Impact factor: 2.671

2.  Corosolic acid: antiangiogenic activity and safety of intravitreal injection in rats eyes.

Authors:  Cibele Rodrigues Toledo; Vinícius Viana Pereira; Lays Fernanda Nunes Dourado; Mayara Rodrigues Brandão Paiva; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2019-02-26       Impact factor: 2.379

3.  Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats.

Authors:  Tobias Peters; Seong-Woo Kim; Vinicius Castro; Krunoslav Stingl; Torsten Strasser; Sylvia Bolz; Ulrich Schraermeyer; George Mihov; MengMeng Zong; Vanessa Andres-Guerrero; Rocio Herrero Vanrell; Aylvin A Dias; Neil R Cameron; Eberhart Zrenner
Journal:  Biomaterials       Date:  2017-02-07       Impact factor: 12.479

Review 4.  Pharmacokinetic aspects of retinal drug delivery.

Authors:  Eva M Del Amo; Anna-Kaisa Rimpelä; Emma Heikkinen; Otto K Kari; Eva Ramsay; Tatu Lajunen; Mechthild Schmitt; Laura Pelkonen; Madhushree Bhattacharya; Dominique Richardson; Astrid Subrizi; Tiina Turunen; Mika Reinisalo; Jaakko Itkonen; Elisa Toropainen; Marco Casteleijn; Heidi Kidron; Maxim Antopolsky; Kati-Sisko Vellonen; Marika Ruponen; Arto Urtti
Journal:  Prog Retin Eye Res       Date:  2016-12-24       Impact factor: 21.198

Review 5.  Investigating the Hypothesis of Stress System Dysregulation as a Risk Factor for Central Serous Chorioretinopathy: A Literature Mini-Review.

Authors:  Fabio Scarinci; Cristina Mihaela Ghiciuc; Francesca Romana Patacchioli; Maura Palmery; Mariacristina Parravano
Journal:  Curr Eye Res       Date:  2019-01-28       Impact factor: 2.424

6.  Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.

Authors:  Ramin Nourinia; Mozhgan Rezaei Kanavi; Amir Kaharkaboudi; Seyed Iman Taghavi; Seyed Javid Aldavood; Soesiawati R Darjatmoko; Shoujian Wang; Zafer Gurel; Jeremy A Lavine; Sare Safi; Hamid Ahmadieh; Narsis Daftarian; Nader Sheibani
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 7.  Dosage form modification and oral drug delivery in older people.

Authors:  Esther T L Lau; Kathryn J Steadman; Julie A Y Cichero; Lisa M Nissen
Journal:  Adv Drug Deliv Rev       Date:  2018-04-13       Impact factor: 15.470

8.  Safety of intravitreal clindamycin in albino rabbit eyes.

Authors:  Zohar Habot-Wilner; Orit Mazza; Jonathan Shahar; Amir Massarweh; Irit Mann; Anat Loewenstein; Ido Perlman
Journal:  Doc Ophthalmol       Date:  2017-07-25       Impact factor: 2.379

9.  Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.

Authors:  Javier A Montero; Jose M Ruiz-Moreno; Eugenia Sanchis-Merino; Santiago Perez-Martin
Journal:  Retina       Date:  2013-03       Impact factor: 4.256

Review 10.  Congenital vascular malformations of the retina and choroid.

Authors:  H Heimann; B Damato
Journal:  Eye (Lond)       Date:  2009-12-18       Impact factor: 3.775

View more
  2 in total

1.  Anti-angiogenic activity and safety of intraocular application of triterpenes.

Authors:  Cibele Rodrigues Toledo; Vinicius Viana Pereira; Lucienir Pains Duarte; Grasiely Faria Sousa; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2021-05-26       Impact factor: 2.379

2.  Alternative management of central serous chorioretinopathy using intravitreal metoprolol.

Authors:  Annelise Nicotti Gonçalves; Ingrid U Scott; Rodrigo Jorge
Journal:  Int J Retina Vitreous       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.